Filtered By:
Condition: Atrial Fibrillation
Management: Medicaid
This page shows you your search results in order of relevance. This is page number 2.
Order by Relevance | Date
Total 31 results found since Jan 2013.
Prominent cardiologist calls for a halt to Watchman implants
A prominent cardiologist is calling for a stop to left atrial appendage closure procedures using Boston Scientific‘s (NYSE:BSX) Watchman device, claiming the procedures, which seek to reduce stroke in patients with nonvalvular atrial fibrillation, result in the opposite.
Dr. John Mandrola argues that randomized, controlled trials of the Watchman, designed for LAA closure, showed the device failed to reduce ischemic stroke, despite being designed for just that purpose.
“Yet we look away; or we let advocates distract us with complicated statistics,” Dr. Mandrola wrote in an article on Medscape. “Iâ€...
Source: Mass Device - November 10, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Boston Scientific Source Type: news
Early improvement after IV tPA at the largest safety-net hospital in New England: the Boston Medical Center experience (P6.232)
CONCLUSIONS: Neurologic improvement within 24 hours was seen in half of our cohort. Patients who improved benefited despite high baseline NIHSS scores and multiple comorbidities. Interestingly time to needle onset was not a significant predictor for early improvement. Further efforts to include underserved populations in clinical trials should be undertaken to clarify key predictors of early improvement after tPA infusion in this population.Disclosure: Dr. Tawakul has nothing to disclose. Dr. Ge has nothing to disclose. Dr. Lau has nothing to disclose. Dr. Nguyen has nothing to disclose. Dr. Romero has nothing to disclose....
Source: Neurology - April 8, 2015 Category: Neurology Authors: Tawakul, A., Ge, G., Lau, H., Nguyen, T., Romero, J., Babikian, V., Kase, C., Masoud, H. Tags: Cerebrovascular Disease and Interventional Neurology: Acute Thrombolysis Source Type: research
Abstract 14: Clinical Characteristics and Treatment Patterns of Medicaid Patients with Atrial Fibrillation: Insights From the ORBIT-AF I Registry Session Title: Concurrent Session IIB: Oral Abstracts - Quality of Care
Conclusions: In a contemporary, community-based AF cohort, Medicaid patients had a greater comorbidity burden and higher stroke risk, yet were less likely to receive OAC compared with those with other forms of insurance.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: O'Brien, E. C., Kim, S., Thomas, L., Fonarow, G. C., Mahaffey, K. W., Kowey, P. R., Gersh, B. J., Burton, P. S., Piccini, J. P., Peterson, E. D. Tags: Session Title: Concurrent Session IIB: Oral Abstracts - Quality of Care Source Type: research
Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry Health Services and Outcomes Research
Conclusions
In a contemporary AF cohort, use of OAC overall and use of NOACs were not significantly lower among Medicaid patients relative to others. However, among warfarin users, Medicaid patients spent less time in therapeutic range compared with those with other forms of insurance.
Source: JAHA:Journal of the American Heart Association - May 3, 2016 Category: Cardiology Authors: O'Brien, E. C., Kim, S., Thomas, L., Fonarow, G. C., Kowey, P. R., Mahaffey, K. W., Gersh, B. J., Piccini, J. P., Peterson, E. D. Tags: Atrial Fibrillation, Primary Prevention, Health Services, Quality and Outcomes Health Services and Outcomes Research Source Type: research
Who Should Be Referred for Left Atrial Appendage Occlusion Therapy?
Opinion statementAtrial fibrillation (AF) is the most common cardiac arrhythmia affecting approximately 7 million individuals in USA. It is one of the most significant arrhythmias, which accounts for a majority of embolic strokes, especially in elderly individuals. Although oral anti-coagulation is beneficial in lowering the risk of stroke, 1 in 10 patients have a contra-indication to warfarin therapy. Among patients who do tolerate either warfarin or novel oral anticoagulant (NOAC), major or recurrent bleeding, intracranial bleeds, etc. often lead to interruption of anti-coagulation. Previous studies have reported that>...
Source: Current Treatment Options in Cardiovascular Medicine - May 2, 2017 Category: Cardiology Source Type: research
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
ConclusionIn over one million patients with NVAF, our results suggest differences in anticoagulation treatment persistence across OAC agents, even after accounting for clinical events after OAC initiation. It is important for clinicians and patients to take these differences into consideration, especially as non-persistence to OAC therapy is associated with thromboembolic complications.
Source: American Journal of Cardiovascular Drugs - October 21, 2021 Category: Cardiology Source Type: research
As some hail new antibody treatment for Alzheimer ’s, safety and benefit questions persist
In a packed San Francisco conference room with a celebratory atmosphere, upbeat company representatives and scientists yesterday presented detailed clinical trial data on the first Alzheimer’s treatment shown to clearly, albeit modestly, slow the disease’s normal cognitive decline. The antibody therapy has buoyed a field marked by decades of failures. Now, it appears to be on the cusp of being greenlit by the U.S. Food and Drug Administration (FDA). Yet other researchers warn of potential risks, including brain swelling and brain hemorrhages that were linked to the recently disclosed deaths of two trial participants wh...
Source: Science of Aging Knowledge Environment - December 1, 2022 Category: Geriatrics Source Type: research
Association between Demographic Characteristics and Hospital Admission in Patients Presenting to the Emergency Department for Transient Neurological Attack (P6.277)
Conclusions:Among patients presenting to the ED with TNA, female sex and race are associated with decreased odds of admission, even after adjusting for socioeconomic and vascular risk factors. Further studies are warranted to determine the public health impact of our results.Disclosure: Dr. Kummer has nothing to disclose. Dr. Parikh has nothing to disclose. Dr. Merkler has nothing to disclose. Dr. Kamel has received personal compensation for activities with Genentech as a speaker. Dr. Kamel has received personal compensation in an editorial capacity for Journal Watch Neurology.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Kummer, B., Parikh, N., Merkler, A., Kamel, H. Tags: Cerebrovascular Disease Health Services Research Source Type: research
Trends in the Longitudinal Utilization of Oral Anticoagulants Among Newly Diagnosed Atrial Fibrillation Patients With Commercial, Medicare, and Medicaid Insurance
Long-term oral anticoagulation (OAC) is recommended for stroke prevention for most patients with atrial fibrillation (AF) and elevated stroke risk.1 While trends in initiation of OAC have been described,2,3 long-term trends in utilization of OAC in patients continuously followed for AF have not been adequately explored. Some healthcare systems adapted anticoagulation services to respond to disruptions during the COVID-19 pandemic.4 We thus investigated how OACs were utilized in patients with newly diagnosed AF from 2018 to 2021 across 3 insurance types: Medicare, Medicaid, and commercial.
Source: The American Journal of Cardiology - July 28, 2023 Category: Cardiology Authors: Jun Soo Lee, Sola Han, Nicole L. Therrien, Chanhyun Park, Feijun Luo, Utibe R. Essien Tags: Brief report Source Type: research
National utilization patterns of warfarin use in older patients with atrial fibrillation: a population-based study of Medicare Part D beneficiaries
Source: Annals of Pharmacotherapy
Area: Evidence > Medicines Management > References
Background: Although warfarin therapy reduces stroke incidence in patients with atrial fibrillation (AF), the rate of warfarin use in this population remains low. In 2008, the US Medicare Part D programme was expanded to pay for medications for Medicare enrollees.
Objective: To examine rates and predictors of warfarin use in Medicare Part D beneficiaries with AF.
Methods: This population-based retrospective cohort study used claims data from 41,447 Medicare beneficiaries aged 66 and older with at least 2 AF diagnoses in ...
Source: NeLM - Cardiovascular Medicine - January 24, 2013 Category: Cardiology Source Type: news
Abstract 20: Public Reporting of Mortality Rates for Cardiovascular Conditions Did Not Improve Patient Outcomes Session Title: Concurrent II Session A: Oral Abstracts on Policy Issues
Conclusions: We found that mortality rates for publicly reported conditions were improving slightly during the period when only processes of care were being reported, but that these improvements slowed or reversed once public reporting of mortality rates began. These findings suggest that public reporting may be necessary, but is clearly not sufficient, to improve patient outcomes.
Source: Circulation: Cardiovascular Quality and Outcomes - June 2, 2014 Category: Cardiology Authors: Joynt, K. E., Orav, E. J., Jha, A. K. Tags: Session Title: Concurrent II Session A: Oral Abstracts on Policy Issues Source Type: research
Comparative Persistence on β-Blockers Versus Calcium Channel Blockers for Ventricular Rate Control in Nonelderly Patients With Atrial Fibrillation.
CONCLUSIONS: Evidence suggests that nonelderly AF patients, when prescribed rate-control therapy, persist longer on BBs than CCBs. Because this is the first long-term study comparing the 2 drug classes in the nonelderly population, further research is suggested.
PMID: 25280975 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - October 3, 2014 Category: Drugs & Pharmacology Authors: Desai VC, Kelton CM, Metzger AH, Cavanaugh TM, Guo JJ, Heaton PC Tags: Ann Pharmacother Source Type: research
MassDevice.com +5 | The top 5 medtech stories for April 21, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. US gov’t delays CMS hospital rating system
The Obama Administration is holding off from publishing new hospital-quality ratings over concerns raised by healthcare providers and Congress over the methodology of the ratings sys...
Source: Mass Device - April 21, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Cooper gets $982K to combat disparities in heart care
The Bristol-Myers Squibb Foundation is providing a $982,000 grant to support a project by Cooper University Health Care ’s Urban Health Institute to address disparities in heart care.
The initiative, called "Reducing Disparities in Cardiovascular Care through Optimization of Risk Factors in Vulnerable Populations," will:
The project will target Medicaid patients from Camden and the surrounding region with a his tory of atrial fibrillation, heart attack or stroke, who are failing medical treatment…
Source: bizjournals.com Health Care:Biotechnology headlines - January 16, 2018 Category: Biotechnology Authors: John George Source Type: news
CMS Requirements for Mandatory Shared Decision Making for Cardiac Procedures and Other Tests
This Viewpoint discusses Centers for Medicare& Medicaid Services (CMS) policies requiring physicians to engage patients in shared decision making prior to implantation of an implantable cardioverter-defibrillator, lung cancer screening, and left atrial appendage closure for stroke prevention in atrial fibrillation, and argues that better guidance is needed if the requirements are to promote meaningful shared decisions.
Source: JAMA - Journal of the American Medical Association - June 4, 2018 Category: General Medicine Source Type: research
